The Origin: Dr. Foster’s Story
The Beginning of the End for Lead Aprons
After a debilitating spinal injury from years of wearing lead, Rampart founder and interventional cardiologist Dr. Bob Foster was nearly forced to walk away from the profession he loved.
The protection meant to keep him safe was slowly breaking him.
That moment became a mission: build a better way.
“I knew we could protect clinicians without putting their health at risk. So we built Rampart for everyone in the room.” – Dr. Bob Foster
Our Core Values
We Lead with H.E.A.R.T.
H
High Character: We do the right thing – even if no one is watching.
E
Engaged Gifting: We believe everyone has a unique strength to contribute.
A
Analytical: We seek truth through data, curiosity, and clarity.
R
Respectful: We treat every person with dignity.
T
Tenacity: We don’t quit when it gets tough – we dig in.
H
High Character: We do the right thing – even if no one is watching.
E
Engaged Gifting: We believe everyone has a unique strength to to contribute.
A
Analytical: We seek truth through data, curiosity, and clarity.
R
Respectful: We treat every person with dignity.
T
Tenacity: We don’t quit when it gets tough – we dig in.
What Sets Us Apart
Total
Protection
The only apron-free solution built for total body, total team protection.
Clinically Proven,
Data-First
Trusted by top institutions with peer-reviewed outcomes and real-world results.
Variance
Experts
Unmatched experience guiding states and hospitals through lead-free adoption.
Exclusive
Technology
Proprietary ClearShield Bismuth acrylic — proven and ready to scale
NEWS & PRESS RELEASES
NEWS & PRESS RELEASES
Rampart IC Announces the Acquisition of ClearShield
Rampart IC, a leader in next-generation radiation shielding for interventional suites, has announced its acquisition of ClearShield, a U.S.-based manufacturer of patented, lead-free, radiation-attenuating acrylic.
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
Rampart IC, a Birmingham-based medical technology company, announced the successful close of its $21.6 million Series B funding round led by Vensana Capital.
RAMPART IC adds Dr. Eric Secemsky to its Medical Advisory Board
Rampart IC has announced that Dr. Eric A. Secemsky, a leading interventional cardiologist and Director of Vascular Intervention at Beth Israel Deaconess Medical Center, has joined its Medical Advisory Board.
Brief Radiation Exposure Using Rampart vs Standard Lead Aprons and Shields During Invasive Cardiovascular Procedures
Chronic radiation exposure and orthopedic injuries are well-described occupational hazards to cardiac catheterization laboratory teams.
May/June 2025 Supplement – The Radiation Safety Revolution
The Next Generation of Interventional Team Protection
June 2025 Supplement – The Radiation Safety Revolution
The Next Generation of Interventional Team Protection
Interested in career opportunities at Rampart?
Please make sure to follow RAMPART on social media for the latest.
Interested in career opportunities at Rampart?
Please make sure to follow RAMPART on social media for the latest.